Hill Publishing Group | contact@hillpublisher.com
Location:Home > Journals > International Journal of Clinical and Experimental Medicine Research > 2019 > 2
Journals
Contact Information
Hill Publishing Group
8825 53rd Ave
Elmhurst, NY 11373, USA
E-mail: contact@hillpublisher.com

International Journal of Clinical and Experimental Medicine Research

MiR-140-5p Targeted YES1 Inhibits Proliferation of Lung Cancer Cell A549

Author:Xiaoyu Wang, Yanhong Yang, Zhenzhen Wang, Zishu Zhao, Haixia wang Date:April 01,2019 Hits:

Abstract

Objective: To test the expression difference of mir-140-5p between lung cancer tissues and lung tissues, and to observe whether miR-140-5p can regulate the expression of YES1, a proto-oncogene, so as to affect cell proliferation and apoptosis. This study provides research direction for the accumulation of data for targeted treatment of lung adenocarcinoma. Methods: The clinical information related to 45 NSCLC cancer cases was collected, and the expression differences of MiR-140-5p between tumor and para-carcinoma tissues was tested by qRT-PCR. After transfection for 48h, A549 cells were divided into a MiR-140-5p mimic group and a control group. Apoptosis of cells in each group was detected by flow cytometry. According to the predicted action sites of MiR-140-5p in YES1 from bioinformatics, whole-gene synthesis of 3’utr sequences containing target sites and mutant 3’utr sequences was performed, and dual-fluorescent vector detection was performed to investigate whether YES1 was the target gene of MiR-140-5p. Results: By comparing the expression of MiR-140-5p in tumor and para-carcinoma tissues by fluorescence PCR, it was found that the expression of MiR-140-5p in para-carcinoma tissues was much higher than that in tumor tissues (P < 0.05). Flow cytometry was used to detect the apoptosis of lung adenocarcinoma cells transfected with MiR-140-5p, and it was confirmed that MiR-140-5p could promote the apoptosis of lung cancer cells. According to the predicted action sites of MiR-140-5p in YES1 from bioinformatics, the 3’utr sequence containing the target sites and the mutant 3’utr sequence were synthesized, and the fluorescence reporter vector detection confirmed that YES1 was the target gene of MiR-140-5p.



References

[1]    Li Bing. (2007) . Comprehensive diagnosis and treatment strategy of non-small cell lung cancer -- evaluation and analysis of NCCN oncology clinical practice guidelines (2006 second edition) [J]. Journal of medicine and philosophy,, 28(14): 66-67. 

[2]    Gozuacik, D., Akkoc, Y., Ozturk, D.G., et al. (2017) Autophagy-Regulating microRNAs and cancer. Frontiers in Oncology, 7, 65. https://doi.org/10.3389/fonc.2017.00065 

[3]   Valentina, F.L., Ami, N.I., Jiang, W.G. and Cui, Y. (2017) Therapeutic role of MiR-140 for the Treatment of Non-small Cell Lung Cancer. Anticancer Research, 37, 4319-4327. 

[4]   Jeong, H.C. (2014) Clinical Aspect of MicroRNA in Lung Cancer. Tuberc Respir Dis. 2014. 77(2), 60-64. https://doi. org/10.4046/trd.2014.77.2.60 

[5]   Yu J, Zhang W, Tang H, et al. Septin 2 accelerates the progression of biliary tract cancer and is negatively regulated by mir-140-5p[J]. Gene, 2016, 589(1): 20-26. 

[6]    Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis[J]. Cancer Cell, 2006, 9(3): 189-198. 

[7]    Tan X, Qin W, Zhang L, et al. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis[J]. Clin Cancer Res, 2011, 17(21): 6802-6811. 

[8]   Kong XM, Zhang GH, Huo YK, et al. MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2[J]. Int J Clin Exp Pathol, 2015, 8(10):12845-12852. 

[9]   Dong W, Yao C, Teng X, et al. MiR-140-3p suppressed cell growth and invasion by downregulating the expression of ATP8A1 in non-small cell lung cancer[J]. Tumour Biol, 2016,37(3): 2973-2985. 

[10]  Ling, H., Ai, J., Hui, L., et al. (2016) Integrative miRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer. Oncotarget, 7, 8441-8454. 

[11]  Zhang YX, Yan YF, Liu YM, et al. Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth[J]. Cell Death Dis, 2016,7(12): e2528. 

[12]  Fang zheng. (2017). Mechanism of microrna-140-5p regulating YES1 in inhibiting the occurrence and development of gastric cancer. 

Full-Text HTML

MiR-140-5p Targeted YES1 Inhibits Proliferation of Lung Cancer Cell A549
Xiaoyu Wang 
Chengde Medical College, An’yuan road, Shuangqiao District, Chengde City, Hebei province, 067000, China
Yanhong Yang 
Qinhuangdao First Hospital, No. 258 Wenhua Road, Haigang District, Qinhuangdao city, Hebei province, 066000
Zhenzhen Wang
Qinhuangdao First Hospital, No. 258 Wenhua Road, Haigang District, Qinhuangdao city, Hebei province, 066000
Zishu Zhao 
Chengde Medical College, An’yuan road, Shuangqiao District, Chengde City, Hebei province, 067000, China
Haixia wang
Hebei Medical University, Shijiazhuang Hebei Medical University, 050000, China
*Corresponding    author:    Yang    yanhong, Qinhuangdao First Hospital, No. 258 Wenhua Road,  Haigang   district,  Qinhuangdao  city, Hebei province,China; +8613223353870
How   to   cite   this   paper:   Xiaoyu   Wang, Yanhong Yang, Zhenzhen Wang, Zishu Zhao, Haixia wang. (2019)   MiR-140-5p Targeted  YES1  Inhibits  Proliferation  of  Lung  Cancer Cell A549.  International  Journal  of  Clinical and Experimental Medicine Research, 3(2), 100-105. 
DOI: 10.26855/ijcemr.2019.04.001 



>> No Data
Copyright © 2019 Hill Publishing Group Inc. All Rights Reserved.